NICE recommends Genomic Health’s breast cancer test

NICE recommends Genomic Health’s breast cancer test


Diagnostic testing provider Genomic Health has announced that the UK’s National Institute for Health…

BiotechnologyEuropeGenomic HealthOncologyRegulationWomen's Health

Ligand enters global license deal for women's health product


Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

New data on Amgen's Prolia and Merck & Co's odanacatib presented at ASBMR meeting


Amgen (Nasdaq: AMGN), the world's largest biotech firm, has presented data from several Prolia (denosumab)…

AmgenAnti-Arthritics/RheumaticsBiotechnologyMerck & CoodanacatibPharmaceuticalProliaResearchWomen's Health

BioSante female libido drug flops in Ph III studies


its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

Back to top